| HRMY | SC 13G/A | neutral | 2/10 | BlackRock filed an amended Schedule 13G for Harmony Biosciences Holdings, reporting a 12.6% stake (7,361,888 shares) as | Oct 27, 2026 |
| ACN | GOVT-CONTRACT | neutral | 2/10 | Accenture Federal Services LLC received a $151.5M firm-fixed-price task order from the Air Force for ICBM FENCES enginee | Oct 27, 2026 |
| BA | GOVT-CONTRACT | neutral | 3/10 | Boeing received a $499.8M modification to its Apache AH-64 engineering services contract with the U.S. Army, extending s | Oct 27, 2026 |
| MCK | GOVT-CONTRACT | neutral | 3/10 | McKesson Medical-Surgical Government Solutions LLC, a subsidiary of McKesson Corp, received a fixed-price IDIQ contract | Oct 27, 2026 |
| JBIO | SC 13G | neutral | 3/10 | BlackRock, Inc. filed a new Schedule 13G disclosing beneficial ownership of 3,323,301 shares of Jade Biosciences, Inc. c | Oct 27, 2026 |
| SNX | SC 13G/A | neutral | 2/10 | BlackRock filed an amended Schedule 13G for TD SYNNEX CORP, reporting beneficial ownership of 7,376,169 shares (9.2% of | Oct 27, 2026 |
| TWI | SC 13G/A | neutral | 2/10 | BlackRock Inc. filed an amended Schedule 13G for Titan International Inc. (TWI), reporting beneficial ownership of 4,194 | Oct 27, 2026 |
| TYRA | SC 13G/A | neutral | 3/10 | BlackRock, Inc. filed an amendment to its Schedule 13G for Tyra Biosciences, reporting a 4.8% beneficial ownership stake | Oct 27, 2026 |
| VIR | SC 13G/A | neutral | 3/10 | BlackRock, Inc. filed an amendment to its Schedule 13G for Vir Biotechnology, disclosing beneficial ownership of 20,905, | Oct 27, 2026 |
| ZSQR | SC 13G | neutral | 4/10 | BlackRock, Inc. filed a new Schedule 13G disclosing a 5.1% passive stake in Z Squared Inc., representing 2,720,485 share | Oct 27, 2026 |
| ASB | SC 13G/A | neutral | 3/10 | BlackRock Inc. filed an amended Schedule 13G for Associated Banc-Corp, reporting beneficial ownership of 21,086,676 comm | Oct 27, 2026 |
| WRB | SC 13G/A | neutral | 3/10 | BlackRock filed an amended Schedule 13G for W. R. Berkley, reporting a 4.6% passive stake (17,215,830 shares) as of Sept | Oct 27, 2026 |
| SAM | SC 13G/A | neutral | 3/10 | BlackRock filed an amended Schedule 13G for Boston Beer, reporting beneficial ownership of 1,104,030 shares (13.4% of Cl | Oct 27, 2026 |
| EAT | SC 13G/A | neutral | 3/10 | BlackRock filed an amended Schedule 13G disclosing beneficial ownership of 5,294,768 shares of Brinker International (EA | Oct 27, 2026 |
| CLX | SC 13G/A | neutral | 2/10 | BlackRock Inc. filed an amended Schedule 13G disclosing beneficial ownership of 7,665,771 shares of Clorox (CLX) common | Oct 27, 2026 |
| FMC | SC 13G/A | neutral | 4/10 | BlackRock filed an amended Schedule 13G disclosing a 12.4% passive stake in FMC Corp as of September 30, 2026, up from a | Oct 27, 2026 |
| GTX | SC 13G/A | neutral | 3/10 | BlackRock Inc. filed an amended Schedule 13G for Garrett Motion Inc., reporting beneficial ownership of 13,861,647 commo | Oct 27, 2026 |
| GT | SC 13G/A | neutral | 3/10 | BlackRock Inc. filed an amended Schedule 13G disclosing a 14.6% passive stake in Goodyear Tire & Rubber as of September | Oct 27, 2026 |
| FDXF | SC 13G/A | neutral | 3/10 | BlackRock Inc. filed an amendment to its Schedule 13G for FedEx Freight Holding Company, Inc., reporting beneficial owne | Oct 27, 2026 |
| CLBK | SC 13G | neutral | 3/10 | BlackRock, Inc. filed a Schedule 13G disclosing a 7.6% passive stake in Columbia Financial, Inc. as of September 30, 202 | Oct 27, 2026 |
| AVY | SC 13G/A | neutral | 3/10 | BlackRock filed an amended Schedule 13G disclosing a 6.5% passive stake in Avery Dennison Corp as of September 30, 2026, | Oct 27, 2026 |
| TRAX | SC 13G/A | neutral | 2/10 | BlackRock, Inc. filed an amended Schedule 13G disclosing a 7.2% passive stake in First Tracks Biotherapeutics, Inc. as o | Oct 27, 2026 |
| CAH | GOVT-CONTRACT | neutral | 4/10 | Cardinal Health received a $1.5B ceiling IDIQ contract from the Defense Logistics Agency for the Medical Surgical Prime | Oct 27, 2026 |
| STTK | SC 13G | neutral | 3/10 | BlackRock, Inc. filed a Schedule 13G disclosing a 5.3% passive stake in Shattuck Labs, Inc., representing 5,339,458 shar | Oct 27, 2026 |
| TGTX | SC 13G/A | neutral | 2/10 | BlackRock filed an amended Schedule 13G disclosing beneficial ownership of 21,190,534 shares of TG Therapeutics common s | Oct 27, 2026 |
| SLS | SC 13G/A | neutral | 3/10 | BlackRock filed an amended Schedule 13G disclosing a 7.9% passive stake in SELLAS Life Sciences Group as of September 30 | Oct 27, 2026 |
| VVX | SC 13G/A | neutral | 3/10 | BlackRock filed an amended Schedule 13G disclosing beneficial ownership of 4,963,274 shares of V2X, Inc. (15.8% of outst | Oct 27, 2026 |
| VOYG | SC 13G/A | neutral | 3/10 | BlackRock, Inc. filed an amended Schedule 13G disclosing a passive stake of 8.1% (4,495,467 shares) in Voyager Technolog | Oct 27, 2026 |
| SWKS | SC 13G/A | neutral | 3/10 | BlackRock Inc. filed an amended Schedule 13G disclosing a 7.0% passive stake in Skyworks Solutions as of September 30, 2 | Oct 27, 2026 |
| VCTR | SC 13G/A | neutral | 3/10 | BlackRock filed an amended Schedule 13G disclosing a 11.3% passive stake in Victory Capital Holdings as of September 30, | Oct 27, 2026 |